ArticleFrontiers in cardiovascular medicine2022

Nicotine and novel tobacco products drive adverse cardiac remodeling and dysfunction in preclinical studies.

Nicholas D Fried et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.